Search Results 1121-1130 of 18465 for hepatitis

1. A Study of the Effectiveness and Safety of Vedolizumab Compared to Adalimumab for Participants with Ulcerative Colitis - Mayo Clinic

   Has chronic hepatitis B virus (HBV) infection* or chronic hepatitis C virus (HCV) infection (* HBV immune participants, ie, being hepatitis B surface ...

2. The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis (ExTINGUISH) - Mayo Clinic

   Active hepatitis B or C established with positive hepatitis B serology (hepatitis B surface antigen and core antigen) and/or positive hepatitis C PCR ...

3. A Study of Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for Relapsed Multiple Myeloma - Mayo Clinic

   ... hepatitis B (defined by a positive test for hepatitis B surface antigen [HBsAg]) at registration or ≤3 months prior to registration. Note: Participants ...

4. Mayo Clinic expert: 3 advances lead to more lifesaving organ transplants

   It preserves the donated lung in a machine outside the body. Lungs can also be restored to a condition suitable for transplant. 3. Organs from hepatitis C- ...

5. A Phase 1B/​2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies (ARTACUS) - Mayo Clinic

   Active infection with hepatitis B virus (HBV), hepatitis C virus (HCV) or human immunodeficiency virus (HIV). Any history of transplant-related viral ...

6. Minocycline (topical application route) - Mayo Clinic

   Autoimmune syndromes (including drug-induced lupus-like syndrome, autoimmune hepatitis, vasculitis and serum sickness) may occur while using this medicine.

7. Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease - Mayo Clinic

   HBV immune participants (ie, being hepatitis B surface antigen [HBsAg] negative and hepatitis B antibody positive) may, however, be included. History of any ...

8. Radiopharmaceutical therapy shows favorable results for people with tough-to-treat meningioma brain tumors, Mayo Clinic study finds

   No patients experienced life-threatening side effects, while 10 had severely low blood counts, one had grade 3 hepatitis and one had a grade 3 seizure possibly ...

9. A Study Of The Pan-KRAS Inhibitor LY4066434 In Participants With KRAS Mutant Solid Tumors - Mayo Clinic

   * Have known active hepatitis B virus (HBV), hepatitis C virus (HCV) and untreated HIV infection * Have other active malignancy unless in remission with ...

10. Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies - Mayo Clinic

    hepatitis B core antibody [anti-HBc] and absence of HBsAg) are eligible ... positive for hepatitis C (HCV) antibody are eligible only if polymerase chain reaction